FF
GBT

FourThought Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

FourThought Financial’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,271
Closed -$41K – 1598
2022
Q2 		$41K Buy
1,271
+216
+20% +$6.32K 0.01% 665
2022
Q1 		$37K Hold
1,055
– – ﹤0.01% 751
2021
Q4 		$31K Hold
1,055
– – ﹤0.01% 819
2021
Q3 		$26K Buy
1,055
+52
+5% +$1.53K ﹤0.01% 890
2021
Q2 		$35K Sell
1,003
-5,459
-84% -$213K ﹤0.01% 813
2021
Q1 		$263K Buy
6,462
+527
+9% +$24.2K 0.04% 306
2020
Q4 		$257K Buy
+5,935
New +$293K 0.04% 296

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FourThought Financial's GBT Position: Q3 2022 in Review

FourThought Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 1,271 shares — an estimated $41K sold.

FourThought Financial first reported a position in GBT in Q4 2020 and held it in 7 quarters. The position peaked at $263K in Q1 2021. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • FourThought Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • FourThought Financial sold 1,271 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $41K.
  • FourThought Financial first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 7 quarters.
  • FourThought Financial's Global Blood Therapeutics, Inc. position peaked at $263K in Q1 2021.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.